World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 80 16844 15838 8442 7805 461 80271

Fred D. Lublin publications per year

The chart shows the history of publications by Fred D. Lublin between 1974 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Fred D. Lublin published across 52 years, from 1974 to 2025, averaging 9.4 papers a year. Output peaked at 34 publications in 2016. 18 of the 487 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1974 to 2025. Vertical axis: number of publications, 0 to 34. Peak 34 publications in 2016. 1974: 1 publication 1975: 0 publications 1976: 0 publications 1977: 0 publications 1978: 1 publication 1979: 2 publications 1980: 1 publication 1981: 2 publications 1982: 2 publications 1983: 2 publications 1984: 3 publications 1985: 2 publications 1986: 3 publications 1987: 13 publications 1988: 9 publications 1989: 1 publication 1990: 2 publications 1991: 8 publications 1992: 6 publications 1993: 10 publications 1994: 13 publications 1995: 9 publications 1996: 11 publications 1997: 12 publications 1998: 2 publications 1999: 6 publications 2000: 3 publications 2001: 6 publications 2002: 6 publications 2003: 5 publications 2004: 6 publications 2005: 15 publications 2006: 15 publications 2007: 13 publications 2008: 12 publications 2009: 13 publications 2010: 4 publications 2011: 8 publications 2012: 12 publications 2013: 21 publications 2014: 24 publications 2015: 29 publications 2016: 34 publications 2017: 31 publications 2018: 20 publications 2019: 7 publications 2020: 19 publications 2021: 18 publications 2022: 15 publications 2023: 12 publications 2024: 8 publications 2025: 10 publications
1974 2025

487 publications in total across all disciplines

View publications per year as a table
Fred D. Lublin: publications per year, 1974 to 2025
Year Publications
1974 1
1975 0
1976 0
1977 0
1978 1
1979 2
1980 1
1981 2
1982 2
1983 2
1984 3
1985 2
1986 3
1987 13
1988 9
1989 1
1990 2
1991 8
1992 6
1993 10
1994 13
1995 9
1996 11
1997 12
1998 2
1999 6
2000 3
2001 6
2002 6
2003 5
2004 6
2005 15
2006 15
2007 13
2008 12
2009 13
2010 4
2011 8
2012 12
2013 21
2014 24
2015 29
2016 34
2017 31
2018 20
2019 7
2020 19
2021 18
2022 15
2023 12
2024 8
2025 10
Total 487
Download as CSV

Fred D. Lublin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Fred D. Lublin sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 461–480 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 461 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751 461
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Fred D. Lublin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Fred D. Lublin sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 80–81 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972 80
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Fred D. Lublin is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their primary research focuses on multiple sclerosis and related neurological disorders, with significant contributions to the understanding of disease mechanisms and clinical treatment outcomes.

The scientist's work spans a wide range of medical fields with a concentration in medicine, pathology and forensic medicine, neurology, rheumatology, molecular biology, and epidemiology. Their research topics prominently include multiple sclerosis research studies, peripheral neuropathies and disorders, rheumatoid arthritis research and therapies, polyomavirus and related diseases, SARS-CoV-2 and COVID-19 research, liver diseases and immunity, and autoimmune and inflammatory disorders research.

Recent publications by Fred D. Lublin highlight their involvement in multiple sclerosis research. Some notable papers are:

  • How patients with multiple sclerosis acquire disability, 2022, Brain
  • The 2013 clinical course descriptors for multiple sclerosis, 2020, Neurology

Though not a direct author on all recent influential papers in the field, they are associated with highly cited studies such as "Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study," published in 2021 in JAMA Neurology, demonstrating relevance in ongoing clinical trial research.

Fred D. Lublin frequently collaborates with other researchers in their field. Frequent co-authors include:

  • Gary Cutter
  • Sylvia Klineova
  • Bruce Cree
  • Stephen Krieger
  • Jerry S. Wolinsky

Publications are prominently featured in several scientific venues, including:

  • Neurology
  • Multiple Sclerosis and Related Disorders
  • Multiple Sclerosis Journal
  • The American Journal of Gastroenterology
  • Brain

Best Publications

  • Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

    Chris H Polman;Stephen C Reingold;Brenda Banwell;Michel Clanet

  • Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis

    W. Ian McDonald;Alistair Compston;Gilles Edan;Donald E Goodkin

  • Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

    Alan J. Thompson;Brenda L. Banwell;Frederik Barkhof;Frederik Barkhof;William M. Carroll

  • Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

    Chris H. Polman;Stephen C. Reingold;Gilles Edan;Massimo Filippi

  • Defining the clinical course of multiple sclerosis Results of an international survey

    Fred D. Lublin;Stephen C. Reingold

  • A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

    Chris H. Polman;Eva Havrdova;Michael Hutchinson;Ludwig Kappos

  • Defining the clinical course of multiple sclerosis: The 2013 revisions

    Fred D. Lublin;Stephen C. Reingold;Jeffrey A. Cohen;Gary R. Cutter

  • Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

    Stephen L. Hauser;Amit Bar-Or;Giancarlo Comi;Gavin Giovannoni

  • Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

    Xavier Montalban;Stephen L. Hauser;Ludwig Kappos;Douglas L. Arnold

  • Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

    Richard A. Rudick;William H. Stuart;Peter A. Calabresi;Christian Confavreux

  • Development of a multiple sclerosis functional composite as a clinical trial outcome measure

    Gary R. Cutter;Monika L. Baier;Richard A. Rudick;Diane L. Cookfair

  • New multiple sclerosis phenotypic classification.

    Fred D. Lublin

  • Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines.

    D. S. Goodin;Elliot Frohman;G. P. Garmany;J. Halper

  • Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.

    Peter A. Calabresi;Ernst Wilhelm Radue;Douglas Goodin;Douglas Jeffery

  • Differential diagnosis of suspected multiple sclerosis: a consensus approach

    D. H. Miller;B. G. Weinshenker;M. Filippi;B. L. Banwell

  • Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.

    Bruce A C Cree;Jeffrey L Bennett;Ho Jin Kim;Brian G Weinshenker

  • Effect of relapses on development of residual deficit in multiple sclerosis

    Fred D. Lublin;Monika Baier;Gary Cutter

  • Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis

    D. H. Miller;P. S. Albert;F. Barkhof;G. Francis

  • Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial

    Jerry S. Wolinsky;Ponnada A. Narayana;Paul O'Connor;Patricia K. Coyle

  • Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force

    Richard Rudick;Jack Antel;Christian Confavreux;Gary Cutter

Frequent Co-Authors

Jerry S. Wolinsky
Jerry S. Wolinsky The University of Texas Health Science Center at Houston
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Gary Cutter
Gary Cutter University of Alabama at Birmingham
Chris H. Polman
Chris H. Polman VU University Medical Center
Gavin Giovannoni
Gavin Giovannoni Queen Mary University of London
Eva Havrdova
Eva Havrdova Charles University
Matilde Inglese
Matilde Inglese University of Genoa
Peter A. Calabresi
Peter A. Calabresi Johns Hopkins University School of Medicine
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona
Hans-Peter Hartung
Hans-Peter Hartung Heinrich Heine University Düsseldorf

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative or supplemental degrees can open new doors in the medical field, even if you aren’t pursuing a traditional MD or DO in the USA. Many students consider online healthcare degrees for greater flexibility and faster career advancement. For instance, those interested in healthcare administration can benefit from choosing a cahme accredited online mha program, which ensures the degree meets rigorous quality standards and is respected by employers nationwide.

Registered nurses aiming to expand their qualifications often look for the best online rn to bsn programs without clinical requirements. These options allow nurses to balance work, family, and study while accelerating their academic progress. Similarly, those seeking leadership and advanced practice roles may choose accelerated msn to dnp programs to obtain the highest nursing credentials more quickly.

For professionals keen to avoid traditional clinical rotations, there are also online dnp programs without clinicals. These alternatives are ideal for nurses and administrators looking to upskill or move into advanced positions remotely, offering convenience without sacrificing educational quality.

Best Scientists Citing Fred D. Lublin

Trending Scientists